Inmagene
PublicInmagene is now publicly traded
The data on this page reflects Inmagene's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Private Placement
Jul 25, 2025
Est. Valuation at Exit
$347.22M
Total Funding Raised
$216M
Company Overview
Inmagene operates in Biotech and is based in San Diego, California. It has raised $216M.
Inmagene is a biotechnology company dedicated to developing innovative therapeutics for immunological and inflammatory diseases.
Sector
Biotech
AI Layer
Non-AI
Inmagene Comparables
Compare Inmagene with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Elemental Biologics | 48% |
For institutional investors. Book with your work email.
Inmagene Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Jul 25, 2025 | ||||
| Series C | Jun 1, 2021 | ||||
| Series B | Nov 9, 2020 | ||||
| Series A | Feb 1, 2020 |
For institutional investors. Book with your work email.
Inmagene Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HighLight Capital | Series C |
| SCVC | Series B |
| Omega Funds | Private Placement |
| Highlight Capital | Series C |
| Jiangsu Honghui Equity Investment Management | Series C |
| Triwise Capital | Series C |
| Blue Owl Capital | Private Placement |
For institutional investors. Book with your work email.
Inmagene Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.